Viewing Study NCT03197012


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-03-19 @ 2:21 AM
Study NCT ID: NCT03197012
Status: COMPLETED
Last Update Posted: 2020-07-07
First Post: 2017-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
Sponsor: Thomas Hope
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neuroendocrine tumor (NET) View
None Peptide Receptor Radionuclide Therapy (PRRT) View
None somatostatin receptor (SSTR) View